{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T08:37:35Z","timestamp":1792485455756,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T00:00:00Z","timestamp":1511308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pancreatology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.pan.2017.11.011","type":"journal-article","created":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T02:16:38Z","timestamp":1511403398000},"page":"2-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":740,"title":["International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017"],"prefix":"10.1016","volume":"18","author":[{"given":"Shuji","family":"Isaji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shugo","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5995-5432","authenticated-orcid":false,"given":"John A.","family":"Windsor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Bassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Fern\u00e1ndez-del Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thilo","family":"Hackert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoi","family":"Hayasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew H.G.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun-Whe","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Kishiwada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohisa","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph W.","family":"Michalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Wolfgang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pan.2017.11.011_bib1","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jamcollsurg.2007.12.020","article-title":"Borderline resectable pancreatic cancer: the importance of this emerging stage of dis- ease","volume":"206","author":"Katz","year":"2008","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.pan.2017.11.011_bib2","article-title":"Is neoadjuvant chemoradiation important in borderline resectable pancreatic cancer (BRPC)? Clinical and surgical outcomes associated with preoperative FOLFIRINOX alone in BRPC","volume":"34","author":"Kim","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.pan.2017.11.011_bib3","doi-asserted-by":"crossref","first-page":"e161137","DOI":"10.1001\/jamasurg.2016.1137","article-title":"Preoperative modified FOLFIRINOX treatment followed by capecitabine-based chemoradiation for borderline resectable pancreatic cancer: alliance for clinical trials in Oncology trial A021101","volume":"151","author":"Katz","year":"2016","journal-title":"JAMA Surg"},{"issue":"39","key":"10.1016\/j.pan.2017.11.011_bib4","doi-asserted-by":"crossref","first-page":"e1647","DOI":"10.1097\/MD.0000000000001647","article-title":"Inverse probability of treatment weighting analysis of upfront surgery versus neoadjuvant chemoradiotherapy followed by surgery for pancreatic adenocarcinoma with arterial abutment","volume":"94","author":"Fujii","year":"2015","journal-title":"Med Baltim"},{"key":"10.1016\/j.pan.2017.11.011_bib5","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1245\/s10434-014-3486-z","article-title":"Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival","volume":"21","author":"Rose","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.pan.2017.11.011_bib6","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/MPA.0000000000000059","article-title":"Gemcitabine-based chemoradiotherapy followed by surgery for borderline resectable and locally unresectable pancreatic ductal adenocarcinoma: significance of the CA19-9 reduction rate and intratumoral human equilibrative nucleoside transporter 1 expression","volume":"43","author":"Kobayashi","year":"2014","journal-title":"Pancreas"},{"key":"10.1016\/j.pan.2017.11.011_bib7","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1002\/cncr.28117","article-title":"A\u00a0multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer","volume":"119","author":"Kim","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.pan.2017.11.011_bib8","doi-asserted-by":"crossref","first-page":"5749","DOI":"10.1002\/cncr.27636","article-title":"Response of borderline pancreatic cancer to neoadjuvant therapy is not reflected by radiographic criteria","volume":"118","author":"Katz","year":"2012","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.pan.2017.11.011_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1091-255X(01)80010-X","article-title":"Preoperative chemoradiation for marginally resectable adenocarcinoma of the pan- creas","volume":"5","author":"Mehta","year":"2001","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"8","key":"10.1016\/j.pan.2017.11.011_bib10","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1245\/ASO.2006.08.011","article-title":"Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy","volume":"13","author":"Varadhachary","year":"2006","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.pan.2017.11.011_bib11","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1245\/s10434-009-0409-5","article-title":"AHPBA\/SSO\/SSAT consensus conference on resectable and borderline resectable pancreatic cancer: rationale and overview of the conference","volume":"16","author":"Vauthey","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.pan.2017.11.011_bib12","doi-asserted-by":"crossref","first-page":"703","DOI":"10.6004\/jnccn.2012.0073","article-title":"National comprehensive cancer networks. Pancreatic adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines","volume":"10","author":"Tempero","year":"2012","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"8","key":"10.1016\/j.pan.2017.11.011_bib13","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1245\/s10434-013-2886-9","article-title":"Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial design","volume":"20","author":"Katz","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.pan.2017.11.011_bib14","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1148\/radiol.13131184","article-title":"Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association","volume":"270","author":"Al-Hawary","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.pan.2017.11.011_bib15","series-title":"General rules for the study of pancreatic cancer","author":"Japan Pancreas Society","year":"2016"},{"key":"10.1016\/j.pan.2017.11.011_bib16","series-title":"multimodal management of borderline resectable pancreatic cancer edited by Katz MHG and ahmad SA","first-page":"265","article-title":"Surgery for borderline pancreatic cancer: the Japanese experience","author":"Isaji","year":"2016"},{"issue":"7","key":"10.1016\/j.pan.2017.11.011_bib17","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/jhbp.451","article-title":"Surgical pitfalls of jejunal vein anatomy in pancreaticoduodenectomy","volume":"24","author":"Ishikawa","year":"2017","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"issue":"8","key":"10.1016\/j.pan.2017.11.011_bib18","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.acra.2008.03.005","article-title":"Assessment of pancreatic tumor resectability with multidetector computed tomography: semiautomated console-generated images versus dedicated workstation-generated images","volume":"15","author":"Singh","year":"2008","journal-title":"Acad Radiol"},{"issue":"1","key":"10.1016\/j.pan.2017.11.011_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/SLA.0b013e318237872e","article-title":"Correlation between radiographic classification and pathological grade of portal vein wall invasion in pancreatic head cancer","volume":"255","author":"Nakao","year":"2012","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.pan.2017.11.011_bib20","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s11605-014-2495-3","article-title":"Anterior approach to the superior mesenteric artery by using nerve plexus hanging maneuver for borderline resectable pancreatic head carcinoma","volume":"18","author":"Mizuno","year":"2014","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"1","key":"10.1016\/j.pan.2017.11.011_bib21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/01.sla.0000258608.52615.5a","article-title":"Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic body cancer: long-term results","volume":"246","author":"Hirano","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.pan.2017.11.011_bib22","series-title":"Classification of malignant tumors (UICC international union against cancer) 7th ed","author":"Sobin","year":"2009"},{"key":"10.1016\/j.pan.2017.11.011_bib23","series-title":"TNM Classification of malignant tumors","author":"James","year":"2016"},{"key":"10.1016\/j.pan.2017.11.011_bib24","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.hpb.2016.04.007","article-title":"Positive para-aortic lymph nodes following pancreatectomy for pancreatic cancer. Systematic review and meta-analysis of impact on short term survival and association with clinicopathologic features","volume":"18","author":"Agalianos","year":"2016","journal-title":"HPB"},{"issue":"6","key":"10.1016\/j.pan.2017.11.011_bib25","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1245\/s10434-011-2211-4","article-title":"Defined clinical classifications are associated with outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapy","volume":"19","author":"Tzeng","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"21","key":"10.1016\/j.pan.2017.11.011_bib26","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1200\/JCO.2016.67.5553","article-title":"Potentially curable pancreatic cancer: american society of clinical Oncology clinical practice guideline","volume":"34","author":"Khorana","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pan.2017.11.011_bib27","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1200\/JCO.2005.05.3934","article-title":"Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma","volume":"24","author":"Ferrone","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pan.2017.11.011_bib28","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1007\/s11605-009-0849-z","article-title":"Predictive and prognostic value of CA 19-9 in resected pancreatic adenocarcinoma","volume":"13","author":"Barton","year":"2009","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"7","key":"10.1016\/j.pan.2017.11.011_bib29","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1245\/s10434-012-2809-1","article-title":"CA19-9 in potentially resectable pancreatic cancer: perspective to adjust surgical and perioperative therapy","volume":"20","author":"Hartwig","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.pan.2017.11.011_bib30","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/SLA.0000000000001763","article-title":"Multi-institutional validation study of the american Joint commission on cancer (8th edition) Changes for T and N staging in patients with pancreatic adenocarcinoma","volume":"265","author":"Allen","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.pan.2017.11.011_bib31","series-title":"TNM classification of malignant tumours","year":"2016"},{"issue":"5","key":"10.1016\/j.pan.2017.11.011_bib32","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s10147-012-0474-9","article-title":"Performance status of patients is the major prognostic factor at all stages of pancreatic cancer","volume":"18","author":"Tas","year":"2013","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.pan.2017.11.011_bib33","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s11605-013-2371-6","article-title":"Morbidity and mortality after pancreaticoduodenectomy in patients with borderline resectable Type C clinical classification","volume":"18","author":"Tzeng","year":"2014","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"4","key":"10.1016\/j.pan.2017.11.011_bib34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.pan.2015.04.004","article-title":"Host systemic inflammatory response influences outcome in pancreatic cancer","volume":"15","author":"Imrie","year":"2015","journal-title":"Pancreatology"},{"issue":"6","key":"10.1016\/j.pan.2017.11.011_bib35","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.surg.2014.02.001","article-title":"International study group of pancreatic surgery. Borderline resectable pancreatic cancer: a consensus statement by the international study group of pancreatic surgery (ISGPS)","volume":"155","author":"Bockhorn","year":"2014","journal-title":"Surgery"}],"container-title":["Pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390317308864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390317308864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T16:06:52Z","timestamp":1761408412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1424390317308864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S1424390317308864"],"URL":"https:\/\/doi.org\/10.1016\/j.pan.2017.11.011","relation":{},"ISSN":["1424-3903"],"issn-type":[{"value":"1424-3903","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017","name":"articletitle","label":"Article Title"},{"value":"Pancreatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pan.2017.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier B.V. on behalf of IAP and EPC.","name":"copyright","label":"Copyright"}]}}